On 13 October 2026, Pope Leo XIV, 71, underwent a successful thoracic operation at Rome’s Agostino Gemelli University Hospital [S1]. This report, published following subsequent updates, details the newly confirmed surgical success, diagnosis, and current hospitalization status. The procedure removed the lower lobe of his right lung utilizing a video-assisted thoracoscopic surgery technique [S2]. Intraoperative histology confirmed a diagnosis of lung adenocarcinoma, which is a common form of non-small cell lung cancer [S1].

Surgery Duration and Hospital Recovery

According to updates from the Vatican press office [S1], the operation lasted approximately 90 minutes while the Pope spent about three hours total in the operating room [S4]. He recovered without immediate complications and returned safely to his tenth-floor hospital room [S1].

Hospitalization and Immediate Cancellations

The Vatican stated that the Pope is expected to remain hospitalized for at least one week to recover from the procedure [S1]. In response to the surgery and ongoing recovery period, all public audiences and scheduled events for Pope Leo XIV have been cancelled through 20 October 2026 [S1].

As of the initial announcements, the Vatican has not disclosed the specific cancer stage or whether lymph nodes were involved in the diagnosis [S1]. Officials have also not announced any immediate plans regarding secondary treatments such as chemotherapy [S1].

Medical Context and Post-Operative Outlook

While medical bulletins establish the immediate success of the 90-minute thoracic operation at Rome’s Agostino Gemelli University Hospital, independent oncological observations emphasize that post-operative recovery timelines dictate broader lifestyle restrictions [S2]. Specifically, independent medical guidance highlights that standard protocols caution against air travel for at least three weeks following pulmonary lobe resections, creating a direct clinical friction with the pontiff's scheduled international itinerary [S7].

Furthermore, the absence of publicly released staging data or lymph node involvement metrics leaves critical prognostic indicators unaddressed by the Holy See press office [S1]. Because the Vatican has refrained from detailing whether adjuvant therapies will succeed the tenth-floor recovery phase, observers must evaluate the 71-year-old pontiff's trajectory strictly through officially confirmed milestones such as the 20 October 2026 audience resumption threshold [S1].

Implications for International Travel and Next Developments

The timing of the surgery raises questions about the feasibility of the Pope's planned 6-17 November tour of Uruguay, Argentina, and Peru [S1]. Medical guidance from independent oncologists typically advises against undertaking air travel for three weeks following lung surgery [S7].

While the Vatican has outlined the immediate one-week hospitalization timeline, official confirmation regarding whether the South American tour will proceed as scheduled remains unannounced, and travel plans remain uncertain with no final decision disclosed [S2]. Observers are awaiting further medical bulletins from the Holy See press office concerning staging results and travel adjustments [S1].

Future updates from Agostino Gemelli University Hospital are expected to clarify whether adjuvant therapies will be required once pathology evaluations conclude [S4]. Until then, public engagements remain suspended past 20 October 2026 [S1].

The next confirmed developments depend entirely on the release of subsequent Vatican press office statements regarding the 71-year-old pontiff's ongoing post-operative progress [S1].